{"id":"NCT03888066","sponsor":"Vifor Pharma, Inc.","briefTitle":"Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)","officialTitle":"A Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal, Parallel Group Study of Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin Angiotensin Aldosterone System Inhibitor (RAASi) Medications for the Treatment of Heart Failure (DIAMOND)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-04-24","primaryCompletion":"2021-09-02","completion":"2021-09-02","firstPosted":"2019-03-25","resultsPosted":"2023-02-24","lastUpdate":"2023-02-24"},"enrollment":1195,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Hyperkalemia"],"interventions":[{"type":"DRUG","name":"Patiromer","otherNames":["Veltassa"]},{"type":"DRUG","name":"Placebos","otherNames":[]}],"arms":[{"label":"Group 1: Patiromer","type":"EXPERIMENTAL"},{"label":"Group 2: Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess the effects of patiromer compared with placebo on serum K+ in HF patients.","primaryOutcome":{"measure":"Changes in Serum K+ Levels From Baseline","timeFrame":"Mean duration of exposure: 227.9 days for Patiromer and 234.5 days for Placebo","effectByArm":[{"arm":"Patiromer","deltaMin":0.029,"sd":0.019},{"arm":"Placebo","deltaMin":0.127,"sd":0.019}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":3},"locations":{"siteCount":415,"countries":["United States","Argentina","Belgium","Brazil","Bulgaria","Canada","Czechia","France","Georgia","Germany","Hungary","Israel","Italy","Mexico","Netherlands","Poland","Russia","Serbia","Spain","Ukraine","United Kingdom"]},"refs":{"pmids":["39340493","35900838","33608263"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":54,"n":439},"commonTop":["Hyperkalaemia","Hypokalaemia","Hypomagnesaemia","Diarrhoea","Hypotension"]}}